[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100425880":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":11,"centralContacts":11,"locations":11,"responsibleParty":22,"collaborators":11,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":29,"acronym":11,"eligibilityCriteria":30,"healthyVolunteers":26,"sex":31,"minAge":32,"maxAge":11,"enrollmentInfo":33,"targetDuration":11,"studyType":36,"phases":37,"briefSummary":39,"conditions":40,"keywords":43,"overallStatus":51,"whyStopped":11,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":11},{"fullName":5,"class":6},"R-Bio","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Long Term Follow-up after Jointstem Transplantation","EXPERIMENTAL",null,[13],"Drug: JOINTSTEM",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DRUG","JOINTSTEM","JOINTSTEM is an OA treatment that uses autologous adipose-derived mesenchymal stem cells. As it does not use allogenic tissues and is incubated without additional genetic modification or mechanical and chemical modification through differentiation, it is classified as 'autologous cell therapy' and is completely free of immunologic rejection.",[9],[21],"autologous adipose-derived mesenchymal stem cells",{"type":23,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100425880","follow-up-study-for-participants-of-jointstem-investigator-initiated-trial-by-arthroscopy-100425880",false,"NCT04825730","Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy","Long-Term Extension Study of Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy in Patients With K-L Grade III Knee Osteoarthritis After 『JOINTSTEM』 Administration","Inclusion Criteria:\n\n* Participants of Jointstem IIT by arthroscopy (BS-JS-IIT1)\n* Participants who signed informed consent document of this study\n\nExclusion Criteria:\n\n* No applicable","ALL","20 Years",{"count":34,"type":35},14,"ESTIMATED","INTERVENTIONAL",[38],"NA","This clinical trial is conducted to assess the long-term safety of \"jointstem\" in patients with degenerative knee arthritis who participated in the previous BS-JS-IIT1 investigator initiated trial.",[41,42],"Degenerative Arthritis","Knee Arthritis",[44,45,46,47,48,49,50],"Stem cell","Adipose tissue derived mesenchymal stem cell","Osteoarthritis","degenerative arthritis","long term","Biostar","Rbio","NOT_YET_RECRUITING","2022-09-26",{"date":54,"type":55},"2022-09-28","ACTUAL",{"date":57,"type":35},"2023-12-01",{"date":59,"type":35},"2029-12-31",{"name":5,"class":6}]